Evidence map›Paper›PMID 41234539›Full record

ArticleFrontiers in molecular biosciences2025

Decoding the anticancer and biofilm-inhibiting efficacy of

Sangavi Pandi, Nachammai Kathiresan, Gowtham Kumar Subbaraj, Deepali Desai, Chitra Nagarajan, Langeswaran Kulanthaivel

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sangavi PandiCenter for Bioinformatics, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
Nachammai KathiresanDepartment of Biotechnology, Alagappa University, Karaikudi, Tamil Nadu, India.
Gowtham Kumar SubbarajFaculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education (Deemed to be University), Kelambakkam, Tamil Nadu, India.
Deepali DesaiDepartment of Microbiology, Dr. D. Y. Patil Medical College Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, India.
Chitra NagarajanDepartment of Microbiology, Sri Venkateswara Dental College and Hospital (Affiliated to The TN Dr. MGR Medical University), Chennai, India.
Langeswaran KulanthaivelDepartment of Biomedical Science, Alagappa University, Karaikudi, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The study employs GNINA, a deep learning-based docking tool, to evaluate molecular interactions. This work integrates machine learning and molecular modeling methodologies, highlighting the potential of informatics-driven strategies to expedite the discovery of novel plant-based therapies. Results and Discussion: Fluorescence microscopy demonstrated that ADEE effectively inhibited biofilm formation and reduced cell viability at a concentration of 1.56 μg/mL. These findings suggest that ADEE disrupts quorum-sensing signaling pathways and compromises the structural integrity of the biofilm matrix. Further assessments of cytotoxicity revealed a dose-dependent reduction in cancer cell viability, highlighting the potent anticancer properties of ADEE. The study also confirmed the pro-apoptotic effects of ADEE through Hoechst and AO/EB staining techniques. Validation utilizing GNINA-based deep learning techniques demonstrated an enhanced binding affinity and pose stability of compounds derived from ADEE. Molecular dynamics simulations provided insights into the interactions of ADEE with pqsA and CK2, showing more favorable binding characteristics compared to the reference inhibitor. PCA/FEL analyses indicated stable conformations with significant interactions at critical residues. In summary, the phytocompounds identified in ADEE demonstrated enhanced binding affinity and structural stability, indicating promising therapeutic potential for targeting QS-regulated biofilm development and serving as potential anticancer agents.

Indexed as

Adansonia digitataAI-based dockingbiofilm inhibitionMDA-MB-231MMPBSA and PCA/FEL analysismolecular dynamics simulationXP docking

Identifiers

PMID41234539
PMCPMC12605543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.